VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 74 filers reported holding VERVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,218,468 | -23.1% | 6,577,562 | +8.8% | 0.01% | -20.0% |
| Q2 2023 | $113,369,616 | -42.4% | 6,046,380 | -55.7% | 0.01% | +11.1% |
| Q1 2023 | $196,885,402 | +47.3% | 13,653,634 | +97.7% | 0.01% | -30.8% |
| Q4 2022 | $133,619,946 | -48.0% | 6,905,423 | -7.7% | 0.01% | -51.9% |
| Q3 2022 | $257,020,000 | +216.4% | 7,482,350 | +40.8% | 0.03% | +237.5% |
| Q2 2022 | $81,226,000 | -30.4% | 5,315,779 | +3.9% | 0.01% | -11.1% |
| Q1 2022 | $116,746,000 | -36.7% | 5,115,910 | +2.3% | 0.01% | -35.7% |
| Q4 2021 | $184,405,000 | +12.7% | 5,001,483 | +43.6% | 0.01% | +7.7% |
| Q3 2021 | $163,649,000 | -21.3% | 3,481,881 | +0.9% | 0.01% | -18.8% |
| Q2 2021 | $207,851,000 | – | 3,449,794 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
| Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
| Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
| MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
| Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
| ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
| Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
| Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
| Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
| Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |